Veterinary OSHA & DEA requirements in Ohio

§ 01Controlled-substance registration

Ohio requires a terminal distributor license for veterinary clinics that possess controlled substances. Ohio defines "dangerous drug" to include drugs restricted to use by or on the order of a licensed veterinarian, and defines "licensed health professional authorized to prescribe drugs" to include a veterinarian licensed under Chapter 4741 ¹. Ohio also defines "terminal distributor of dangerous drugs" to include persons that have possession, custody, or control of dangerous drugs for purposes other than their own use and consumption ¹.

Ohio Revised Code 4729.541 exempts licensed prescribers and certain prescriber-owned business entities from terminal-distributor licensure in general, but removes that exemption when the person or entity possesses, has custody or control of, and distributes dangerous drugs that are compounded/used for compounding or Schedule I-V controlled substances ². A clinic with controlled substances therefore needs the appropriate Ohio State Board of Pharmacy terminal distributor license; Ohio's license categories define Category III as controlled substances in Schedules I-V ³. Ohio's veterinary-clinic pharmacy rules define a "veterinary clinic" as a facility licensed as a terminal distributor of dangerous drugs under section 4729.54, with a licensed veterinarian serving as responsible person and drugs possessed on-site for administration or personal furnishing ⁴.

Veterinary prescribing/dispensing authority: an Ohio licensed health professional authorized to prescribe drugs, acting in professional practice and under the profession's laws and Board of Pharmacy rules, may prescribe, administer, personally furnish, or cause to be administered under direction and supervision Schedule II-V controlled substances ⁵. Ohio exempts veterinarians from the Schedule II electronic-prescription mandate; each controlled-substance prescription must still be executed, dated, signed, and include the owner name/address for an animal prescription, the prescriber's full name/address/DEA registry number, and the animal species ⁵.

Personally furnished drug label: when a veterinarian personally furnishes a dangerous drug, the container label must show the veterinarian name/address, the owner name and animal identification, drug name/strength, directions, date furnished, and a compounded-drug statement if applicable ⁶. Ohio's controlled-substance label statute also requires pharmacy labels for animal prescriptions to include owner name and animal species, and Schedule II-IV labels must include the federal transfer-warning sentence ⁷.

Storage/access: Ohio veterinary-clinic rules put security and control of dangerous drugs on the responsible person and the terminal distributor. Controlled substances generally must be stored in a securely locked, substantially constructed cabinet or safe, not readily accessible to the public, locked when not in use, with key/code controls; only a veterinarian may access the controlled-substance cabinet or safe except for the stated veterinary-technician access pathways ⁸. Thiafentanil, carfentanil, etorphine hydrochloride, and diprenorphine require the separate enhanced safe/steel-cabinet standard in the same rule ⁸.

The same security rule reaches beyond the controlled-substance safe:

• Hypodermics: during non-business hours, hypodermics must be stored in an area secured by a physical barrier with suitable locks (a substantially constructed cabinet, locked room, or secured facility); during normal business hours, hypodermics must not be stored in areas where members of the public are not supervised by individuals authorized to administer injections ⁸.
• Non-controlled dangerous drugs: the same standard applies — non-business-hours storage behind a physical barrier with suitable locks, and no business-hours storage in areas where members of the public are not supervised by individuals authorized to administer the drugs ⁸.
• Drug refrigerators and freezers: maintain either temperature logs with, at a minimum, daily observations, or a temperature monitoring system capable of detecting and alerting staff of a temperature excursion; develop and implement policies and procedures to respond to any out-of-range readings or excursions; and implement a policy that no food or beverage products are stored in refrigerators or freezers used to store drugs ⁸. The matching record-content requirements are in the recordkeeping section of this kit.
• Multi-dose vials: upon the initial puncture of a multiple-dose vial, label the vial with the date opened; examine multi-dose vials before use for evidence of physical or chemical contamination, and treat as adulterated any vial with particulate matter, precipitates, turbidity, or discoloration, mislabeling, or noticeable coring of the stopper ⁸.

Ohio supplier-license verification before wholesale drug purchases (documented Board roster query)

Before ANY wholesale purchase of dangerous drugs — controlled or non-controlled — Ohio requires a documented check that the seller is properly licensed. Before a terminal distributor of dangerous drugs may purchase dangerous drugs at wholesale, it must query the Board of Pharmacy's online roster (available on the Board's website, www.pharmacy.ohio.gov) to confirm that the seller is licensed to engage in the sale of dangerous drugs under ORC 4729.52, or licensed to engage in the occasional sale or distribution of dangerous drugs at wholesale under rule 4729:5-3-09 ⁹. If no documented query is conducted before a purchase is made, the rule presumes the terminal distributor's purchase of dangerous drugs violates ORC 4729.51 ⁹.

Safe harbor — document a roster query at least annually: a licensed terminal distributor that conducts a documented query at least annually and relies on the results of that query in purchasing dangerous drugs is deemed not to have violated ORC 4729.51 in making the purchase ⁹. Practical workflow for this kit: once a year (calendar it alongside the Ohio annual controlled-substance inventory below), query the Board's online roster for every wholesaler or distributor the clinic purchases from, save a dated copy of each roster result (printout or screenshot) with the clinic's drug-receipt records, and run and document a fresh query before the first purchase from any new supplier.

Sale-side duty: if the clinic ever sells, transfers, or distributes dangerous drugs at wholesale under rule 4729:5-3-09 (for example, an occasional sale of stock to another licensed practice), it must first query the Board's online roster to determine that the purchaser is licensed as a terminal distributor of dangerous drugs — for a limited terminal distributor, also reviewing a current version of that licensee's drug list to ensure the purchaser is authorized to possess the drugs ordered — or as a distributor of dangerous drugs under division 4729:6 ⁹.

Ohio annual controlled-substance inventory (stricter than the federal biennial rule)

Ohio requires a controlled-substance inventory every YEAR. The federal biennial (every-two-years) inventory schedule is NOT sufficient in Ohio. All Category III terminal distributors must complete a controlled-substance inventory in accordance with 21 CFR 1304.11, conducted on an annual basis; the annual inventory may be taken on any date within thirteen months of the previous inventory date ¹⁰. The Board of Pharmacy's inventory guidance states this "is different from the DEA requirement that requires a controlled substance inventory every two years" ¹¹. Wherever this kit anchors a controlled-substance inventory to the federal biennial date, Ohio clinics must instead calendar and complete the inventory annually — following only the federal biennial schedule under-complies in Ohio.

When a drug or compound is added to the controlled-substance schedules by state or federal law, rule, or regulation, the terminal distributor must complete an inventory of all stocks of that drug no later than ten days after it is added to the schedule ¹⁰ — this ten-day duty is triggered by Ohio-only scheduling actions such as xylazine (Ohio Schedule III, 2023 ¹²) even when federal schedules do not change. The responsible person completes and maintains the inventory record at the licensed location, and a clinic commencing business with no controlled substances on hand records that fact as its initial inventory ¹⁰.

Ohio theft/significant-loss reporting (state board duty, in addition to DEA)

The federal baseline in this kit covers the DEA theft/significant-loss pathway (21 CFR 1301.76 / DEA Form 106). Ohio imposes a separate, parallel reporting duty to the State Board of Pharmacy ¹³:

• Immediately upon discovery of the theft or significant loss of ANY dangerous drug or controlled substance — including drugs in transit shipped from or to the licensed location — notify the State Board of Pharmacy by telephone or other Board-determined method; if a controlled substance, also notify DEA under 21 CFR 1301.76; and notify law-enforcement authorities under ORC 2921.22 ¹³.
• Within thirty days of discovery, file the information reported on the federal DEA theft/loss report form with the State Board of Pharmacy, regardless of whether the controlled substances are subsequently recovered or the responsible parties are identified (waiver of the thirty-day limit may be requested from the Board on sufficient cause) ¹³.
• Non-controlled dangerous drugs: report theft or significant loss to the State Board of Pharmacy within thirty days of discovery, again regardless of recovery ¹³.
• Prescription documents: immediately upon discovery, notify the Board and law enforcement of any theft or loss of uncompleted prescription blanks, written prescription orders not yet dispensed, or original prescription orders that have been dispensed ¹³.
• DEA Form 222: immediately upon discovery, notify the Board, law enforcement, and DEA (per 21 CFR 1305.16) of the theft or loss of any DEA Form 222 ¹³.

The veterinary-clinic security rule itself cross-references this duty: the responsible person must report theft or significant loss of drugs kept under the technician-access pathway in accordance with rule 4729:5-3-02 ⁸.

Ohio off-site and ambulatory possession of dangerous drugs (stricter than the federal baseline)

Ohio restricts where a licensed clinic's drugs may be kept — the federal house-call/ambulatory allowance in this kit's baseline is NOT sufficient by itself in Ohio. Ohio rule 4729:5-3-13 prohibits a licensed terminal distributor of dangerous drugs from maintaining possession, custody, or control of dangerous drugs for any purpose at any establishment or place other than the location described in its Board of Pharmacy license, subject to listed exceptions ¹⁴. Two of those exceptions matter for veterinary practice:

• Temporary removal (house calls, farm calls, day trips) — 24-hour return rule: a licensed health professional authorized to prescribe drugs (which includes a veterinarian) may temporarily remove dangerous drugs from the licensed terminal distributor in order to treat current or prospective patients, but the drugs must be returned to the licensed terminal distributor within twenty-four hours, unless otherwise approved by the Board ¹⁴. The prescriber must maintain direct supervision and control over the dangerous drugs and any hypodermics removed; if direct supervision is not provided, the drugs and hypodermics must be physically secured to prevent unauthorized access and stored at temperatures and conditions that ensure drug integrity as stipulated by USP/NF and/or the manufacturer's or distributor's labeling. The responsible person on the terminal distributor license is responsible for compliance with these requirements ¹⁴.
• Veterinarian off-site supply (stocked practice vehicle, satellite site, multi-day rounds): a veterinarian licensed under Chapter 4741 may maintain a supply of dangerous drugs obtained from a licensed terminal distributor at another location in order to treat current or prospective patients, under all of the following conditions ¹⁴: - the veterinarian maintains direct supervision and control over the drugs and any hypodermics; if direct supervision is not provided, they must be physically secured to prevent unauthorized access, with all reasonable efforts made to store the drugs at USP/NF- or labeling-compliant temperatures and conditions; - the drugs are obtained from a single terminal distributor only, with no co-mingling of drug stock from another terminal distributor; - the off-site drugs remain subject to inspection by a Board of Pharmacy agent and to all recordkeeping, labeling, theft or significant-loss reporting, disposal, and inventory requirements of division 4729:5, with records maintained by the terminal distributor in accordance with the veterinary-clinic chapter 4729:5-20; - for controlled substances stored off-site for more than twenty-four hours, the terminal distributor must also keep records of the name, strength, dosage form, and quantity of the controlled substances, the positive identification of the veterinarian who removed the drugs, and the address of the off-site location, with corresponding records for any controlled substances returned to the terminal distributor's inventory from the off-site location; all of these records must be readily retrievable and maintained for at least three years from the date of removal or return; - the responsible person on the terminal distributor license from which the drugs are obtained is responsible for compliance, and a veterinarian's failure to exercise the supervision and control required by ORC 4729.55(B) or the adequate safeguards required by ORC 4729.55(C) is deemed a violation of the rule.

For this rule, "direct supervision" means the authorized individual is in the immediate area and within visual range of the dangerous drugs and/or hypodermics to deter and detect diversion ¹⁴. Wherever this kit's federal baseline treats house-call or ambulatory stock as an extension of the registered location, Ohio clinics must ALSO comply with this rule: same-day removals go back to the licensed location within 24 hours (or get Board approval), and any standing off-site or vehicle stock must be operated under the veterinarian off-site regime above — single-source, no co-mingling, with the removal/return records for controlled substances kept off-site beyond 24 hours.

Ohio-only scheduling: xylazine

Ohio Schedule III includes ketamine, tiletamine/zolazepam, and xylazine ¹². The Ohio Board of Pharmacy's xylazine compliance notice says any Ohio veterinary clinic that possesses controlled substances must obtain a Category 3 terminal distributor license, and specifically tied xylazine possession to Category 3 veterinary-facility licensure after the 2023 enforcement-waiver period ¹⁵.

Federal status watch (pending legislation — NOT law): a federal bill to schedule xylazine, the Combating Illicit Xylazine Act (S. 545, 119th Congress, introduced 2025-02-12), was ordered reported favorably by the Senate Judiciary Committee on 2026-03-26 and placed on the Senate Legislative Calendar (Calendar No. 372) on 2026-04-15; the official bill-status record shows no enacted-law entry — the bill is pending, not enacted ¹⁶. As of this module's verified date, xylazine remains scheduled in Ohio but not federally, so the Ohio-only framing of this section stands. VERIFY quarterly: re-check the bill status each verify.yml cycle; if the Act (or a companion bill) becomes law, re-work this section's Ohio-only framing, the ten-day newly-scheduled-inventory guidance above, and any DEA-registration implications for clinics that stock xylazine.

In-clinic compounding (pointer — not covered by this kit)

The licensure content above covers Ohio's compounding-related licensure trigger (ORC 4729.541(C)) and the compounded-drug label statement, but this kit does not cover compounding practice standards. Ohio's Administrative Code contains a dedicated drug-compounding division (4729:7), whose Chapter 4729:7-3 is titled "Prescriber Compounding" ¹⁷.

§ 02Prescription monitoring program (PDMP)

Ohio's prescription drug monitoring program (PDMP) is the Ohio Automated Rx Reporting System (OARRS), created by the Ohio Board of Pharmacy ¹⁸. Ohio Revised Code 4729.79 requires licensed prescribers who personally furnish controlled substances or other reportable drugs to submit specified data to the Board of Pharmacy, but it expressly says the submission requirement does not apply to a prescriber who is a veterinarian ¹⁹. The parallel pharmacy-reporting statute likewise states it does not apply to a prescriber personally furnishing or administering dangerous drugs to the prescriber's patient ²⁰. Do not build a routine OARRS self-reporting workflow for ordinary in-office veterinary personal furnishing unless the Board of Pharmacy directs otherwise for your specific license or workflow.

Ohio pharmacies that dispense drugs to patients in the state (of the types specified in Board rules) must submit prescription information to the Board's drug database, including prescriber identification, patient identification, the name/strength/national drug code of the drug dispensed, the quantity dispensed, and the number of days' supply ²⁰; OARRS states it collects information on all outpatient controlled-substance prescriptions dispensed by Ohio-licensed pharmacies ¹⁸. A veterinary prescription filled by an outside pharmacy therefore reaches OARRS through the pharmacy's reporting channel — keep prescription records complete enough for the pharmacy to identify the prescriber, owner, animal/species, drug, quantity, and days' supply.

§ 03OSHA: federal or state plan?

Ohio does not operate an OSHA-approved State Plan. Federal OSHA applies directly to private-sector veterinary employers in Ohio, so the federal baseline in this plan is the operative workplace-safety standard; there is no Ohio OSHA overlay for private employers ²¹.

§ 04X-ray & radiation registration

Ohio stationary veterinary facilities must have imaging services available on site or by referral, properly identify images with patient name, owner name, and date, and register all radiation sources with and operate them under Ohio Department of Health rules ²².

Ohio's radiation-generating equipment rules define covered equipment as equipment used for dental, veterinary, or medical purposes, excluding therapeutic radiation-generating equipment ²³. A handler must assure the individual responsible for radiation protection is qualified under the listed pathways, which include a registered veterinary technician trained to operate veterinary radiation-generating equipment ²³. Ohio also requires the handler to assure safe operating procedures and equipment standards such as warning labels, technique-factor indications, beam/filtration requirements, stable tube support, and functioning locks/holding devices ²³.

Each registrant must develop, implement, and maintain a written quality assurance program, readily available in hard copy or electronic form, that addresses equipment evaluations, occupational/public exposure limits, overexposure notifications, safe operating procedures, operator training, QA/QC tests, personnel protection, pregnant-worker exposure policy, ancillary staff radiation-safety training, practitioner-only ordering policies, and an inventory of radiation-generating equipment ²⁴.

Note on applicability: the QA rule's title refers to "medical" radiation-generating equipment, but its text binds "each registrant" ²⁴, and the chapter's definitions expressly cover veterinary use — "veterinary radiation-generating equipment" is a defined term, and "licensed practitioner" includes an individual licensed under Chapter 4741 to practice veterinary medicine ²⁵. This kit treats the written QA program as applying to veterinary registrants because the chapter contains no veterinary exclusion; ODH has not stated this expressly, so confirm per the flag box below.

§ 05Records retention

Veterinary medical records: at least 3 years after the last visit. Ohio veterinary-board rule 4741-1-21 requires the veterinarian to prepare a written or computer record for examinations, diagnoses, treatments, and surgeries, with minimum content including owner contact information, animal/herd/flock identity, exam/treatment/surgery dates, history, findings, lab/radiographic tests and reports, differential diagnosis, procedures/treatments/results, drugs administered/dispensed/prescribed with dosage and route, surgical procedure details, and anesthesia monitoring ²⁶. Individual records are required for each patient except livestock or litters may be kept per-client, and medical records including radiographs must be maintained at least 3 years after the last visit ²⁶.

Controlled-substance records: every licensed health professional authorized to prescribe drugs must keep records of controlled substances received and of controlled substances administered, dispensed, or used other than by prescription; Category III terminal distributors must keep records of controlled substances received or sold ²⁷. Ohio requires those records to show the controlled-substance description, source/recipient information, dates, and for animal use, owner and animal species; every record required by section 3719.07 must be kept 5 years unless Board of Pharmacy rules specify otherwise ²⁷.

Controlled-substance inventory: ANNUAL in Ohio — do not rely on the federal biennial schedule. Ohio rule 4729:5-3-07 requires all Category III terminal distributors to complete a controlled-substance inventory in accordance with 21 CFR 1304.11 on an annual basis; the annual inventory may be taken on any date within thirteen months of the previous inventory date, and all inventory records must be maintained for three years from the completion date and be readily retrievable ¹⁰. A newly scheduled drug or compound (state or federal action) must be inventoried within ten days of being added to the schedule, and a clinic commencing business with no controlled substances on hand records that fact as its initial inventory ¹⁰. The Board of Pharmacy's guidance confirms the annual cadence "is different from the DEA requirement that requires a controlled substance inventory every two years," and states the annual inventory must comply with the same requirements as a DEA inventory: name of substance and total quantity by finished form and commercial container; an exact count or measure for Schedule I or II substances; an estimated count permitted for Schedule III-V unless the container holds more than one thousand tablets or capsules; a separate inventory for each place where controlled substances are possessed; and a record showing zero inventory when no stocks are on hand ¹¹. Ohio clinics should calendar this inventory annually wherever this kit's federal baseline refers to the biennial inventory date.

Ohio veterinary-clinic pharmacy rule 4729:5-20-04 also requires records of all dangerous drugs received, administered, personally furnished, disposed, sold, or transferred; personally furnishing records must include animal identification, owner/caregiver name and address, date furnished, and controlled-substance final association by positive identification; administration records for controlled substances must include positive identification of the licensed or registered health-care professional administering the drug ²⁸. Records under that rule must be readily retrievable and kept on-site for 3 years, unless the terminal distributor notifies the Board about an alternate record location ²⁸. Where the same record supports multiple duties, keep it for the longer applicable retention period.

Controlled-substance disposal records (Ohio specifics on top of the federal witnessed-destruction baseline): controlled-substance disposal records must comply with rule 4729:5-3-01; in addition, if disposal of controlled-substance drug inventory is performed on-site, the record must include the positive identification of two licensed or registered healthcare professionals conducting and witnessing the disposal, one of whom must be the responsible person or the responsible person's designee; disposal of an unused portion of a controlled substance resulting from administration to a patient likewise requires the positive identification of two licensed or registered healthcare professionals conducting and witnessing the disposal; a veterinarian may use an animal aide in lieu of one of the two professionals for either kind of disposal ²⁸. Wherever this kit's federal baseline calls for two-person witnessed destruction or wastage, Ohio clinics must capture these positive-identification and responsible-person-or-designee elements in the disposal record.

Off-site/ambulatory controlled-substance records: if the practice maintains dangerous drugs away from the licensed location under Ohio's temporary-removal rule, also keep the removal/return records described in the off-site possession subsection of this kit's controlled-substances section — name, strength, dosage form, and quantity, positive identification of the removing veterinarian, the off-site address, and corresponding return records, readily retrievable for at least three years from removal or return ¹⁴.

Temperature-monitoring records (the companion record to the drug refrigerator/freezer temperature duty in the storage section): temperature logs must include the date and time of observation, the full name or initials of the individual performing the check, and the temperature recorded — or, for automated temperature-monitoring systems, a report with at minimum the date and time of observation and the temperature recorded; systems that detect and alert on excursions must keep reports covering the date, time, temperature recorded, and length of each excursion ²⁸.

§ 06Sharps & medical waste disposal

Ohio EPA's public FAQ says all veterinary practices are infectious-waste generators and are responsible for handling, packaging, storing, treating, and disposing of infectious wastes under Ohio EPA infectious-waste regulations ²⁹. Ohio EPA's veterinary infectious-waste guidance says infectious sharps must be placed in a sharps container; it also says veterinarians providing services outside the office, such as farm/racetrack care or vaccination clinics, remain responsible for properly managing infectious waste generated during the visit and taking it back to the office for disposal and quantification when applicable ³⁰.

Treat sharps, pathological wastes, vaccines of zoonotic agents, and field-service waste under the Ohio EPA veterinary guidance and your generator category. Use rigid sharps containers for infectious sharps, segregate infectious waste at the point of generation, quantify monthly generation when required, and use an approved treatment/disposal path or infectious-waste hauler.